Drug Use and HIV Risk Outcomes in Opioid-Injecting Men in the Republic of Georgia: Behavioral Treatment+naltrexone Compared to Usual Care

Drug and Alcohol Dependence - Netherlands
doi 10.1016/j.drugalcdep.2011.06.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hiv Infection Among Commercial Sex Workers and Injecting Drug Users in the Czech Republic

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2006English

HIV Risk Behaviours Among Injecting Drug Users in Vietnam: A Review

Science Journal of Public Health
2014English

Spatial Accessibility of Drug Treatment Facilities and the Effects on Locus of Control, Drug Use, and Service Use Among Heroin-Injecting Mexican American Men

International Journal of Drug Policy
MedicineHealth Policy
2014English

Geographic Variability in HIV and Injection Drug Use in Ukraine: Implications for Integration and Expansion of Drug Treatment and HIV Care

International Journal of Drug Policy
MedicineHealth Policy
2015English

Randomized Trial to Reduce Club Drug Use and HIV Risk Behaviors Among Men Who Have Sex With Men.

Journal of Consulting and Clinical Psychology
PsychiatryClinical PsychologyMental Health
2009English

Evidence for Risk Reduction Among Amphetamine-Injecting Men Who Have Sex With Men; Results From National HIV Behavioral Surveillance Surveys in the Seattle Area 2008–2012

AIDS and Behavior
EnvironmentalPublic HealthInfectious DiseasesSocial PsychologyOccupational Health
2014English

The Research on Female Partners of Injecting Drug Users-Gender Aspect and Risk of HIV

Retrovirology
VirologyInfectious Diseases
2012English

Patient-Centred Care in Opioid Agonist Treatment Could Improve Outcomes

CMAJ
Medicine
2019English

Applying a Cognitive-Behavioral Model of HIV Risk to Youths in Psychiatric Care

AIDS Education and Prevention
Public HealthEnvironmentalHealthMedicineInfectious DiseasesOccupational Health
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy